Science submits BCI for vision restoration for CE mark
June 23, 2025
Brain-computer interface (BCI) developer Science Corporation today said it submitted its Prima retinal implant for CE mark approval.
Brain-computer interface (BCI) developer Science Corporation today said it submitted its Prima retinal implant for CE mark approval.
Ambu announced it has received expanded FDA 510(k) clearance for its aScope 5 Cysto HD, making it the first single-use flexible cysto-nephroscope cleared for use in percutaneous nephrolithotomy (PCNL) procedures in the U.S.
FDA clearance positions SMILE Dx as a pioneering AI-powered platform for early detection and diagnosis in dental care, streamlining clinical workflows and improving patient outcomes.
Wearable Device Now Authorized to Support Diagnosis and Monitoring of Sleep Apnea and Related Health Conditions from the Comfort of Home
Magnetic-Assisted Robotic Platform Now Approved for Bariatric and Hiatal Hernia Procedures, Broadening Access to Scar-Reducing Surgical Innovation
SAN JOSE, Calif., June 18, 2025 /PRNewswire/ — Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced that the U.S. Food and Drug Administration (FDA) has approved its integrated sacral neuromodulation (iSNM) system for the treatment of urinary urge incontinence (UUI).
MOUNTAIN VIEW, Calif., June 18, 2025 /PRNewswire/ — Expanding Innovations™ (EI), a rapidly growing spine company specializing in NON-SCREW-based Expandable Technology, today announced U.S. FDA 510(k) clearance for its N-GAGE™ Lumbar Plate System—the company’s first spinal fixation platform as it continues to broaden its procedure-based solutions.
Levita Magnetics announced today that it received expanded FDA 510(k) clearance for its MARS (magnetic-assisted robotic surgery) system.
Beau Monde Health and Wellness is the First Medical Spa and Wellness Clinic in Kansas City to Offer the LIPOcel Treatment, a Non-Surgical, Non-Invasive, Quick 30-minute Treatment that Destroys Stubborn Fat. No Downtime, Virtually Pain Free and delivers Permanent Results.
Corvia Medical announced today that it closed a $55 million funding round to support the advancement of its Corvia atrial shunt.